Proliferative Vitreoretinopathy: Pathobiology and Therapeutic Targets

REFERENCES

• Gonin J. The treatment of detached retina by searing the retinal tears. Arch Ophthalmol 1930; 4: 621–625
   Google Scholar
• Machemer R, Buettner H, Norton E W, Parel J M. Vitrectomy: A pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 1971; 75: 813–820
   PubMedGoogle Scholar
• D'Amico D J. Clinical practice. Primary retinal detachment. N Engl J Med 2008; 359: 2346–2354
   PubMed Web of Science ®Google Scholar
• Charles S, Calzada J, Wood B. Vitreous Microsurgery, 4th ed. Lippincott Williams & Wilkins, Philadelphia 2007; 231
   Google Scholar
• The SPR Study Group. View 2: The case for primary vitrectomy. Br J Ophthalmol 2003; 87: 784–787
   Google Scholar
• Heimann H, Bartz-Schmidt K U, Bornfeld N, Weiss C, Hilgers R D, Foerster M H. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: A prospective randomized multicenter clinical study. Ophthalmology 2007; 114: 2142–2154
   PubMed Web of Science ®Google Scholar
• Campochiaro P A. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 1997; 115: 237–241
   PubMedGoogle Scholar
• Charteris D G. Proliferative vitreoretinopathy: Pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 1995; 79: 953–960
   PubMed Web of Science ®Google Scholar
• Charteris D G, Sethi C S, Lewis G P, Fisher S K. Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye 2002; 16: 369–374
   PubMed Web of Science ®Google Scholar
• Kim I K, Arroyo J G. Mechanisms in proliferative vitreoretinopathy. Ophthalmol Clin North Am 2002; 15: 81–86
   PubMedGoogle Scholar
• Jager R D, Mieler W F, Miller J W. Age-related macular degeneration. N Engl J Med 2008; 358: 2606–2617
   PubMed Web of Science ®Google Scholar
• Stichel C C, Muller H W. The CNS lesion scar: New vistas on an old regeneration barrier. Cell Tissue Res 1998; 294: 1–9
   PubMed Web of Science ®Google Scholar
• Fitch M T, Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008; 209: 294–301
   PubMed Web of Science ®Google Scholar
• Machemer R, Aaberg T M, Freeman H M, Irvine A R, Lean J S, Michels R M. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1991; 112: 159–165
   PubMed Web of Science ®Google Scholar
• The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983; 90: 121–125
   PubMed Web of Science ®Google Scholar
• Charteris D G, Downie J, Aylward G W, Sethi C, Luthert P. Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 2007; 245: 93–100
   PubMed Web of Science ®Google Scholar
• Clarkson J G, Green W R, Massof D. A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol 1977; 84: 1–17
   PubMed Web of Science ®Google Scholar
• Kampik A, Kenyon K R, Michels R G, Green W R, de la Cruz Z C. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol 1981; 99: 1445–1454
   PubMed Web of Science ®Google Scholar
• Schwartz D, de la Cruz Z C, Green W R, Michels R G. Proliferative vitreoretinopathy. Ultrastructural study of 20 retroretinal membranes removed by vitreous surgery. Retina 1988; 8: 275–281
   Google Scholar
• Wilkes S R, Mansour A M, Green W R. Proliferative vitreoretinopathy. Histopathology of retroretinal membranes. Retina 1987; 7: 94–101
   PubMedGoogle Scholar
• Alberts B. Molecular Biology of the Cell, 4th ed. Garland Science, New York 2002
   Google Scholar
• Hiscott P S, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: An immunohistochemical study. Br J Ophthalmol 1984; 68: 708–715
   PubMed Web of Science ®Google Scholar
• Streit W J, Mrak R E, Griffin W S. Microglia and neuroinflammation: A pathological perspective. J Neuroinflammation 2004; 1: 14
   PubMed Web of Science ®Google Scholar
• Stichel-Gunkel C C. The role of microenvironment in axonal regeneration. Influences of lesion-induced changes and glial implants on the regeneration of the postcommissural fornix. Adv Anat Embryol Cell Biol 1997; 137: I–VII; 1–81
   Google Scholar
• Jerdan J A, Pepose J S, Michels R G, Hayashi H, de Bustros S, Sebag M, Glaser B M. Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology 1989; 96: 801–810
   PubMed Web of Science ®Google Scholar
• Morino I, Hiscott P, McKechnie N, Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br J Ophthalmol 1990; 74: 393–399
   PubMed Web of Science ®Google Scholar
• Mitamura Y, Takeuchi S, Ohtsuka K, Matsuda A, Yamamoto T, Yamamoto S, Hiraiwa N, Kusakabe M. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy. Ophthalmologica 2003; 217: 422–425
   Google Scholar
• Hagedorn M, Esser P, Wiedemann P, Heimann K. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ger J Ophthalmol 1993; 2: 28–31
   Google Scholar
• Hiscott P, Hagan S, Heathcote L, Sheridan C M, Groenewald C P, Grierson I, Wong D, Paraoan L. Pathobiology of epiretinal and subretinal membranes: Possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye 2002; 16: 393–403
   Google Scholar
• Sheridan C M, Magee R M, Hiscott P S, Hagan S, Wong D H, McGalliard J N, Grierson I. The role of matricellular proteins thrombospondin-1 and osteonectin during RPE cell migration in proliferative vitreoretinopathy. Curr Eye Res 2002; 25: 279–285
   PubMed Web of Science ®Google Scholar
• David S, Ness R. Heterogeneity of reactive astrocytes. Biology and Pathology of Astrocyte-neuron Interactions, S Fedoroff. Plenum Press, New York 1993
   Google Scholar
• Fernaud-Espinosa I, Nieto-Sampedro M, Bovolenta P. Differential activation of microglia and astrocytes in aniso- and isomorphic gliotic tissue. Glia 1993; 8: 277–291
   PubMed Web of Science ®Google Scholar
• Hatten M E, Liem R K, Shelanski M L, Mason C A. Astroglia in CNS injury. Glia 1991; 4: 233–243
   PubMed Web of Science ®Google Scholar
• Jonas J B, Knorr H L, Budde W M. Prognostic factors in ocular injuries caused by intraocular or retrobulbar foreign bodies. Ophthalmology 2000; 107: 823–828
   PubMed Web of Science ®Google Scholar
• Cardillo J A, Stout J T, LaBree L, Azen S P, Omphroy L, Cui J Z, Kimura H, Hinton D R, Ryan S J. Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 1997; 104: 1166–1173
   PubMed Web of Science ®Google Scholar
• Hiscott P S, Grierson I, Trombetta C J, Rahi A H, Marshall J, McLeod D. Retinal and epiretinal glia–An immunohistochemical study. Br J Ophthalmol 1984; 68: 698–707
   PubMed Web of Science ®Google Scholar
• Vinores S A, Van Niel E, Kim H J, Campochiaro P A. Simultaneous expression of keratin and glial fibrillary acidic protein by the same cells in epiretinal membranes. Invest Ophthalmol Vis Sci 1992; 33: 3361–3366
   PubMed Web of Science ®Google Scholar
• Frayer W C. Reactivity of the retinal pigment epithelium: An experimental and histopathologic study. Trans Am Ophthalmol Soc 1966; 64: 586–643
   PubMedGoogle Scholar
• Mandelcorn M S, Machemer R, Fineberg E, Hersch S B. Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants. Am J Ophthalmol 1975; 80: 227–237
   PubMed Web of Science ®Google Scholar
• Elner S G, Elner V M, Kindzelskii A L, Horino K, Davis H R, Todd R F, 3rd, Glagov S, Petty H R. Human RPE cell lysis of extracellular matrix: Functional urokinase plasminogen activator receptor (uPAR), collagenase and elastase. Exp Eye Res 2003; 76: 585–595
   PubMed Web of Science ®Google Scholar
• Glaser B M, Vidaurri-Leal J, Michels R G, Campochiaro P A. Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology 1993; 100: 466–470
   PubMed Web of Science ®Google Scholar
• Campochiaro P A, Kaden I H, Vidaurri-Leal J, Glaser B M. Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol 1985; 103: 434–436
   PubMedGoogle Scholar
• Cowley M, Conway B P, Campochiaro P A, Kaiser D, Gaskin H. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 1989; 107: 1147–1151
   PubMed Web of Science ®Google Scholar
• Steele F R, Chader G J, Johnson L V, Tombran-Tink J. Pigment epithelium-derived factor: Neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A 1993; 90: 1526–1530
   PubMed Web of Science ®Google Scholar
• Ogata N, Tombran-Tink J, Nishikawa M, Nishimura T, Mitsuma Y, Sakamoto T, Matsumura M. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am J Ophthalmol 2001; 132: 378–382
   PubMed Web of Science ®Google Scholar
• Ogata N, Wang L, Jo N, Tombran-Tink J, Takahashi K, Mrazek D, Matsumura M. Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr Eye Res 2001; 22: 245–252
   PubMed Web of Science ®Google Scholar
• Dawson D W, Volpert O V, Gillis P, Crawford S E, Xu H, Benedict W, Bouck N P. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999; 285: 245–248
   PubMed Web of Science ®Google Scholar
• Feuerstein G Z, Liu T, Barone F C. Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 1994; 6: 341–360
   PubMedGoogle Scholar
• Limb G A, Little B C, Meager A, Ogilvie J A, Wolstencroft R A, Franks W A, Chignell A H, Dumonde D C. Cytokines in proliferative vitreoretinopathy. Eye 1991; 5: 686–693, (Pt 6)
   PubMedGoogle Scholar
• Limb G A, Alam A, Earley O, Green W, Chignell A H, Dumonde D C. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res 1994; 13: 791–798
   PubMed Web of Science ®Google Scholar
• Crowe P D, Walter B N, Mohler K M, Otten-Evans C, Black R A, Ware C F. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 1995; 181: 1205–1210
   PubMed Web of Science ®Google Scholar
• Van Zee K J, Kohno T, Fischer E, Rock C S, Moldawer L L, Lowry S F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89: 4845–4849
   PubMed Web of Science ®Google Scholar
• Sippy B D, Hofman F M, Wright A D, He S, Ryan S J, Hinton D R. Soluble tumor necrosis factor receptors are present in human vitreous and shed by retinal pigment epithelial cells. Exp Eye Res 1996; 63: 311–317
   PubMed Web of Science ®Google Scholar
• Dopp J M, Mackenzie-Graham A, Otero G C, Merrill J E. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 1997; 75: 104–112
   PubMed Web of Science ®Google Scholar
• Limb G A, Hollifield R D, Webster L, Charteris D G, Chignell A H. Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 2001; 42: 1586–1591
   PubMed Web of Science ®Google Scholar
• Matsushima K, Larsen C G, DuBois G C, Oppenheim J J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485–1490
   PubMed Web of Science ®Google Scholar
• Stamatovic S M, Keep R F, Kunkel S L, Andjelkovic A V. Potential role of MCP-1 in endothelial cell tight junction ‘opening’: Signaling via Rho and Rho kinase. J Cell Sci 2003; 116: 4615–4628
   PubMed Web of Science ®Google Scholar
• Kalehua A N, Nagel J E, Whelchel L M, Gides J J, Pyle R S, Smith R J, Kusiak J W, Taub D D. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. Exp Cell Res 2004; 297: 197–211
   Google Scholar
• Eugenin E A, D'Aversa T G, Lopez L, Calderon T M, Berman J W. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 2003; 85: 1299–1311
   PubMed Web of Science ®Google Scholar
• Ishida S, Yamashiro K, Usui T, Kaji Y, Ogura Y, Hida T, Honda Y, Oguchi Y, Adamis A P. Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nat Med 2003; 9: 781–788
   Google Scholar
• Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A, Miyahara S, Nakao S, Yin Y, Benowitz L, Hafezi-Moghadam A, Miller J W. Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A 2007; 104: 2425–2430
   PubMed Web of Science ®Google Scholar
• Elner S G, Elner V M, Jaffe G J, Stuart A, Kunkel S L, Strieter R M. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 1995; 14: 1045–1053
   PubMed Web of Science ®Google Scholar
• Abu el-Asrar A M, Van Damme J, Put W, Veckeneer M, Dralands L, Billiau A, Missotten L. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders. Am J Ophthalmol 1997; 123: 599–606
   PubMed Web of Science ®Google Scholar
• Capeans C, De Rojas M V, Lojo S, Salorio M S. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Retina 1998; 18: 546–550
   PubMed Web of Science ®Google Scholar
• Han Q H, Hui Y N, Du H J, Zhang W J, Ma J X, Wang S Y. Migration of retinal pigment epithelial cells in vitro modulated by monocyte chemotactic protein-1: Enhancement and inhibition. Graefes Arch Clin Exp Ophthalmol 2001; 239: 531–538
   PubMed Web of Science ®Google Scholar
• Campochiaro P A, Glaser B M. Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch Ophthalmol 1985; 103: 576–579
   PubMedGoogle Scholar
• Deuel T F. Polypeptide growth factors: Roles in normal and abnormal cell growth. Annu Rev Cell Biol 1987; 3: 443–492
   PubMedGoogle Scholar
• Harvey A K, Roberge F, Hjelmeland L M. Chemotaxis of rat retinal glia to growth factors found in repairing wounds. Invest Ophthalmol Vis Sci 1987; 28: 1092–1099
   PubMedGoogle Scholar
• Robbins S G, Mixon R N, Wilson D J, Hart C E, Robertson J E, Westra I, Planck S R, Rosenbaum J T. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994; 35: 3649–3663
   PubMed Web of Science ®Google Scholar
• Ross R, Raines E W, Bowen-Pope D F. The biology of platelet-derived growth factor. Cell 1986; 46: 155–169
   PubMed Web of Science ®Google Scholar
• Hart C E, Bowen-Pope D F. Platelet-derived growth factor receptor: Current views of the two-subunit model. J Invest Dermatol 1990; 94: 53S–57S
   PubMed Web of Science ®Google Scholar
• Andrews A, Balciunaite E, Leong F L, Tallquist M, Soriano P, Refojo M, Kazlauskas A. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1999; 40: 2683–2689
   PubMed Web of Science ®Google Scholar
• Ikuno Y, Kazlauskas A. TGFbeta1-dependent contraction of fibroblasts is mediated by the PDGFalpha receptor. Invest Ophthalmol Vis Sci 2002; 43: 41–46
   PubMed Web of Science ®Google Scholar
• Lindahl P, Johansson B R, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997; 277: 242–245
   PubMed Web of Science ®Google Scholar
• Seo M S, Okamoto N, Vinores M A, Vinores S A, Hackett S F, Yamada H, Yamada E, Derevjanik N L, LaRochelle W, Zack D J, Campochiaro P A. Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment. Am J Pathol 2000; 157: 995–1005
   PubMed Web of Science ®Google Scholar
• Saishin Y, Takahashi K, Seo M S, Melia M, Campochiaro P A. The kinase inhibitor PKC412 suppresses epiretinal membrane formation and retinal detachment in mice with proliferative retinopathies. Invest Ophthalmol Vis Sci 2003; 44: 3656–3662
   PubMedGoogle Scholar
• Yamada H, Yamada E, Ando A, Seo M S, Esumi N, Okamoto N, Vinores M, LaRochelle W, Zack D J, Campochiaro P A. Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy. Am J Pathol 2000; 156: 477–487
   PubMedGoogle Scholar
• Mori K, Gehlbach P, Ando A, Dyer G, Lipinsky E, Chaudhry A G, Hackett S F, Campochiaro P A. Retina-specific expression of PDGF-B versus PDGF-A: Vascular versus nonvascular proliferative retinopathy. Invest Ophthalmol Vis Sci 2002; 43: 2001–2006
   PubMed Web of Science ®Google Scholar
• Ikuno Y, Leong F L, Kazlauskas A. PI3K and PLCgamma play a central role in experimental PVR. Invest Ophthalmol Vis Sci 2002; 43: 483–489
   PubMedGoogle Scholar
• Ikuno Y, Kazlauskas A. An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor. Invest Ophthalmol Vis Sci 2002; 43: 2406–2411
   PubMed Web of Science ®Google Scholar
• Chen Y S, Hackett S F, Schoenfeld C L, Vinores M A, Vinores S A, Campochiaro P A. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol 1997; 81: 919–926
   PubMed Web of Science ®Google Scholar
• Schneeberger S A, Hjelmeland L M, Tucker R P, Morse L S. Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes. Am J Ophthalmol 1997; 124: 447–454
   PubMed Web of Science ®Google Scholar
• Terman B I, Dougher-Vermazen M, Carrion M E, Dimitrov D, Armellino D C, Gospodarowicz D, Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187: 1579–1586
   PubMed Web of Science ®Google Scholar
• de Vries C, Escobedo J A, Ueno H, Houck K, Ferrara N, Williams L T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989–991
   PubMed Web of Science ®Google Scholar
• Quinn T P, Peters K G, De Vries C, Ferrara N, Williams L T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A 1993; 90: 7533–7537
   PubMed Web of Science ®Google Scholar
• Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, Plouet J. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995; 164: 385–394
   PubMed Web of Science ®Google Scholar
• Dieudonne S C, La Heij E C, Diederen R M, Kessels A G, Liem A T, Kijlstra A, Hendrikse F. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Ophthalmic Res 2007; 39: 148–154
   PubMedGoogle Scholar
• Silver J. Special issue: Spinal cord regeneration and repair. Exp Neurol 2008; 209: 293
   Google Scholar